08M236 (LAEA), ascending colon, section 3, 5d post-ATI
source_name
Ascending colon
tissue
Ascending colon
treatment
LAEA group (persistent reservoir model): challenged intravenously with a 300 TCID50 dose of barcoded SIVmac239M2; suppressive ART initiated at week 10 post-challenge and maintained for 382 days (~12 months) before analytical treatment interruption (ATI); necropsied 5 days post-ATI, during the pre-viremic eclipse phase.
batch
08M236
tissue preservation_method
fresh frozen, optimal cutting temperature (OCT) compound
slide parameters
V12-N14-006 D1
geo_loc_name
missing
collection_date
missing